Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial

Journal:
The Lancet
Published:
Affiliations:
25
Authors:
102
Institutions Authors Share
The University of Texas MD Anderson Cancer Center, United States of America (USA)
26.750000
26.750000
26.750000
0.57
Massachusetts General Hospital (MGH), United States of America (USA)
2.041667
0.04
UW Medicine, United States of America (USA)
2.041667
0.04
Mayo Clinic, United States of America (USA)
2.041667
0.04
University of Maryland, Baltimore (UMB), United States of America (USA)
1.541667
0.03
University of Florida Health (UF Health), United States of America (USA)
1.041667
0.02
Miami Cancer Institute, United States of America (USA)
1.041667
0.02
Mayo Clinic Hospital - Phoenix, United States of America (USA)
1.041667
0.02
Northwestern Medicine, United States of America (USA)
1.041667
0.02
Barbara Ann Karmanos Cancer Institute, Wayne State University, United States of America (USA)
1.041667
0.02
OU Health Sciences Center (OUHSC), United States of America (USA)
1.041667
0.02
Willis-Knighton Health System, United States of America (USA)
1.041667
0.02
The Winship Cancer Institute of Emory University, United States of America (USA)
1.041667
0.02
University of Pennsylvania (Penn), United States of America (USA)
1.041667
0.02
Inova Schar Cancer Institute, United States of America (USA)
1.041667
0.02
Baylor College of Medicine (BCM), United States of America (USA)
0.541667
0.01
The University of Alabama at Birmingham (UAB), United States of America (USA)
0.541667
0.01
New York Proton Center, United States of America (USA)
0.541667
0.01
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)
0.541667
0.01